Related references
Note: Only part of the references are listed.Preclinical Evaluation of 203/212Pb-Labeled Low-Molecular-Weight Compounds for Targeted Radiopharmaceutical Therapy of Prostate Cancer
Sangeeta Ray Banerjee et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Mathematical Modeling of Preclinical Alpha-Emitter Radiopharmaceutical Therapy
Alireza Karimian et al.
CANCER RESEARCH (2020)
Pb-212 alpha-Radioimmunotherapy Targeting CD38 in Multiple Myeloma: A Preclinical Study
Isabelle Quelven et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Cellular dosimetry of [177Lu]Lu-DOTA-[Tyr3]octreotate radionuclide therapy: the impact of modeling assumptions on the correlation with in vitro cytotoxicity
Giulia Tamborino et al.
EJNMMI PHYSICS (2020)
Targeted alpha therapy for chronic lymphocytic leukaemia and non-Hodgkin's lymphoma with the anti-CD37 radioimmunoconjugate 212Pb-NNV003
Astri Fjelde Maaland et al.
PLOS ONE (2020)
Radiopharmaceutical therapy in cancer: clinical advances and challenges
George Sgouros et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Response of breast cancer carcinoma spheroids to combination therapy with radiation and DNA-PK inhibitor: growth arrest without a change in α/β ratio
Jing Yu et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2020)
Preclinical Investigation of 212Pb-DOTAMTATE for Peptide Receptor Radionuclide Therapy in a Neuroendocrine Tumor Model
Tania A. Rozgaja Stallons et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Drugs That Modify Cholesterol Metabolism Alter the p38/JNK-Mediated Targeted and Nontargeted Response to Alpha and Auger Radioimmunotherapy
Riad Ladjohounlou et al.
CLINICAL CANCER RESEARCH (2019)
Cellular and Genetic Determinants of the Sensitivity of Cancer to α-Particle Irradiation
Brian D. Yard et al.
CANCER RESEARCH (2019)
Clinical evidence of abscopal effect in cutaneous squamous cell carcinoma treated with diffusing alpha emitters radiation therapy: a case report
Salvatore Roberto Bellia et al.
JOURNAL OF CONTEMPORARY BRACHYTHERAPY (2019)
A Robust Method for Assaying the Immunoreactive Fraction in Nonequilibrium Systems
Thibaut Denoel et al.
PHARMACEUTICALS (2019)
212Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models
Benjamin B. Kasten et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Preparation of 212Pb-labeled monoclonal antibody using a novel 224Ra-based generator solution
Sara Westrom et al.
NUCLEAR MEDICINE AND BIOLOGY (2017)
Therapeutic efficacy of α-radioimmunotherapy with different activity levels of the 213Bi-labeled monoclonal antibody MX35 in an ovarian cancer model
Anna Gustafsson-Lutz et al.
EJNMMI RESEARCH (2017)
Measurement of complex DNA damage induction and repair in human cellular systems after exposure to ionizing radiations of varying linear energy transfer (LET)
Zacharenia Nikitaki et al.
FREE RADICAL RESEARCH (2016)
Recent developments in GEANT4
J. Allison et al.
NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT (2016)
Application of Pb-212 for Targeted alpha-particle Therapy (TAT): Pre-clinical and Mechanistic Understanding through to Clinical Translation
Kwon Yong et al.
AIMS MEDICAL SCIENCE (2015)
Toxicological Studies of 212Pb Intravenously or Intraperitoneally Injected into Mice for a Phase 1 Trial
Diane E. Milenic et al.
PHARMACEUTICALS (2015)
Pharmacokinetics and Imaging of 212Pb-TCMC-Trastuzumab After Intraperitoneal Administration in Ovarian Cancer Patients
Ruby F. Meredith et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2014)
MIRD Pamphlet No. 25: MIRDcell V2.0 Software Tool for Dosimetric Analysis of Biologic Response of Multicellular Populations
Behrooz Vaziri et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Dose Escalation and Dosimetry of First-in-Human α Radioimmunotherapy with 212Pb-TCMC-Trastuzumab
Ruby Meredith et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Redefining Relative Biological Effectiveness in the Context of the EQDX Formalism: Implications for Alpha-Particle Emitter Therapy
Robert F. Hobbs et al.
RADIATION RESEARCH (2014)
The potential and hurdles of targeted alpha therapy - clinical trials and beyond
Jorgen Eigqvist et al.
FRONTIERS IN ONCOLOGY (2014)
Biodistribution of 212Pb conjugated trastuzumab in mice
N. R. Schneider et al.
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY (2013)
Methodology for labeling proteins and peptides with lead-212 (212Pb)
Kwamena E. Baidoo et al.
NUCLEAR MEDICINE AND BIOLOGY (2013)
Alpha-Particle Emitting 213Bi-Anti-EGFR Immunoconjugates Eradicate Tumor Cells Independent of Oxygenation
Christian Wulbrand et al.
PLOS ONE (2013)
Accelerated fractionation with a concurrent boost for early stage breast cancer
Gary M. Freedman et al.
RADIOTHERAPY AND ONCOLOGY (2013)
Bioeffect modeling and equieffective dose concepts in radiation oncology Terminology, quantities and units
Soren M. Bentzen et al.
RADIOTHERAPY AND ONCOLOGY (2012)
Delayed repair of radiation induced clustered DNA damage: Friend or foe?
Laura J. Eccles et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2011)
The Therapeutic Effect of Anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity
SaeGwang Park et al.
CANCER CELL (2010)
MIRD Pamphlet No. 22 (Abridged): Radiobiology and Dosimetry of α-Particle Emitters for Targeted Radionuclide Therapy
George Sgouros et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Radiation-induced bystander signalling in cancer therapy
Kevin M. Prise et al.
NATURE REVIEWS CANCER (2009)
An Immunotolerant HER-2/neu Transgenic Mouse Model of Metastatic Breast Cancer
Hong Song et al.
CLINICAL CANCER RESEARCH (2008)
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial
LANCET (2008)
Relative biological effectiveness (RBE) of alpha radiation in cultured porcine aortic endothelial cells
Patricia Thomas et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2007)
Alpha-particle emitting atomic generator (actinium-225)-labeled trastuzumab (herceptin) targeting of breast cancer spheroids:: Efficacy versus HER2/neu expression
ÅM Ballangrud et al.
CLINICAL CANCER RESEARCH (2004)
Share Paper
